Clinical Trial: A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421778) titled 'A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants' on Feb. 12.

Brief Summary: QRL-101-08 is a multiple ascending dose (MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of a novel formulation of QRL-101 in healthy participants.

Study Start Date: Feb. 02

Study Type: INTERVENTIONAL

Condition: Healthy Participant Study

Intervention: DRUG: QRL-101

Multiple-ascending doses of QRL-101 will be orally administered to healthy participants.

DRUG: Placebo

Multiple-ascending doses of comparator placebo will be administered orally to ...